Table 5.
The 18 candidate genes for VSD identified in this study
| Gene | Gene Annotation | CNV type | Hits into gene set | Phenotype (individual number) |
|---|---|---|---|---|
| CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like | loss | ▪◆⋆△ | iVSD (2) cVSD(1) |
| LBX1 | ladybird homeobox 1 | gain | ▪◆△ο | iVSD |
| PAX3 | paired box 3 | gain | ▪◆△ο | iVSD |
| TBX1 | T-box 1 | loss | ▪◆△ | iVSD (2) cVSD(1) |
| PDLIM3 | PDZ and LIM domain 3 | loss | ▪◆ | ASD |
| TXNRD2 | thioredoxin reductase 2 | loss | ▪◆ | iVSD (2) cVSD(1) |
| GP1BB | glycoprotein Ib (platelet), beta polypeptide | loss | ◆△ | iVSD (2) cVSD(1) |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | loss | ◆⋆△ | ASD |
| MYH11 | myosin, heavy chain 11, smooth muscle | gain | ◆△ο | iVSD |
| BMP5 | bone morphogenetic protein 5 | gain | ◆⊿△ο | iVSD |
| EN1 | engrailed homeobox 1 | gain | ◆⊿△ο | cVSD |
| PRKCB | protein kinase C, beta | gain | ◆⊿△ο | cVSD |
| FGF12 | fibroblast growth factor 12 | gain | ◆ο | ASD |
| HIRA | histone cell cycle regulator | loss | ⊿△ο | iVSD (2) cVSD(1) |
| SOX2 | SRY (sex determining region Y)-box 2 | gain | ⊿ο | ASD |
| DGCR2 | DiGeorge syndrome critical region gene 2 | loss | ⊿ο | iVSD (2) cVSD(1) |
| PLK1 | polo-like kinase 1 | gain | △ο | cVSD |
| EGFL6 | EGF-like-domain, multiple 6 | loss | △ de novo | cVSD |
Note: ▪ MGI database, ◆ Genes within Geneset reported in literature and CHD wiki
⊿ Prioritized by Gene set from literature and CHD wiki
⋆Genes within GO and KEGG pathway
△ Prioritized by Gene set from GO and KEGG pathway
ο Genes significantly enriched by IPA
iVSD: isolated VSD; cVSD: complex VSD